Company Profile
Inflect Capital is a venture capital firm dedicated to accelerating healthcare innovation by investing in, incubating, and advising companies. The firm focuses on transforming the future of healthcare through strategic investments in early-stage startups. They are notably backed by Vituity, one of the largest physician-owned partnerships in the United States, which provides a vast network of over 8,000 clinicians across more than 700 practices, serving approximately 13 million patients annually.
Established in 2020, Inflect Capital primarily targets pre-seed, seed, and Series A stage startups that are innovating across the healthcare landscape. Beyond capital investment, the firm operates with a multi-faceted approach, including Inflect Studio, which identifies pressing healthcare challenges and builds new solutions, and Inflect Advisory, which offers invaluable clinician perspectives and industry expertise to leading companies and government entities.
The firm's portfolio includes a diverse range of healthcare technology companies such as Joyful Health, which focuses on AI-powered financial infrastructure for healthcare revenue, Ansible Health for personalized respiratory care, Arcascope for circadian rhythm technology, and ShiftRx, an AI-driven platform. Other notable investments include Arise, Ayble Health, Karoo, Macro Trials, and Rely Health, all contributing to various aspects of healthcare improvement.
The team at Inflect Capital comprises experienced professionals across its investment, studio, and advisory arms. Key members of Inflect Capital include Andrew Smith, Nika Duan, David Feldman, and Cindy Moccio. The Inflect Studio team includes Josh Tamayo-Sarver and Lauren Sweeney, while Inflect Advisory leverages the expertise of individuals like Rick Newell and Lindsay Kriger. This collective expertise, particularly the deep clinical insights from Vituity's network, allows Inflect Capital to act as an early design partner, go-to-market accelerant, and knowledgeable healthcare advisor for its portfolio companies.
News & Signals (0)
No linked news activity found for this company.